200,000+ products from a single source!

sales@angenechem.com

Home > Supersensitive Odorant Receptor Underscores Pleiotropic Roles of Indoles in Mosquito Ecology

Supersensitive Odorant Receptor Underscores Pleiotropic Roles of Indoles in Mosquito Ecology

 

 

David Ruel, Esther Yakir and Jonathan D. Bohbot*

Department of Entomology, The Hebrew University of Jerusalem, Rehovot, Israel

 

 

INTRODUCTION
Aromatic and heterocyclic compounds play an important role in the ecology of adult mosquitoes as indicated by the odor space of the Anopheles gambiae odorant receptor (OR) repertoire (Carey et al., 2010; Wang et al., 2010). Specifically, indole (IUPAC name, 1H-indole) and skatole (IUPAC name, 3-methylindole) are respectively detected  by the narrowly  tuned  Or2 and Or10 paralogous genes found in Culex quinquefasciatus (Hughes et al., 2010; Pelletier  et al., 2010), Aedes aegypti and An. gambiae (Carey et al., 2010; Wang et al., 2010) reflecting their ancestral origin (Bohbot et al., 2011). Due to the sensitive and selective nature of the OR2-indole and OR10-skatole interactions, they have been referred to as the ‘‘indolergic’’ receptors (Bohbot and Pitts, 2015).
Indole and skatole are released by a wide variety of organisms but are mainly synthesized by bacteria (Elgaali et al., 2002; Schulz and Dickschat, 2007; Lindh et al., 2008; Hubbard et al., 2015), fungi (Chen et al., 2014; Tomberlin et al., 2017) and plants (Turlings et al., 1991; Frey et al., 2000; Ober, 2005). In adult mosquitoes, both compounds have been proposed to mediate oviposition site (Blackwell and Johnson, 2000) and host-locating behaviors (Cork, 1996).  However, their exact ecological role(s) remain complex since indoles are major constituents of floral (Knudsen   et al., 2006) and animal scents (Meijerink et al., 2001; Lee et al., 2015). Interestingly, indolic compounds play additional ecological roles in mosquito larvae (Xia et al., 2008; Scialò et al., 2012).

 

Or2 is expressed in the adult and larval stages of Ae. aegypti (Bohbot et al., 2007) and An. gambiae (Hill et al., 2002; Xia et al., 2008). Or10 expression is more complex: in An. gambiae, Or10 is expressed both in larvae and adults. In Ae. Aegypti, Or10 is only expressed in adults, while a third paralog named Or9, is expressed in the larval antenna (Bohbot et al., 2007). Based  on pharmacological studies, we have suggested that receptor sensitivity towards odorants in the nanomolar concentration range is a predictor of OR-semiochemical relationships (Bohbot and Pitts, 2015). The activation of AaegOR9 by indole in the low micromolar concentration range (Bohbot et al., 2011) indicated that a more potent indolic cognate ligand selectively activates this receptor.

 

Using a reverse chemical ecology approach, we set out to identify a potential cognate ligand for  this  larval-expressed  Or9 gene (Supplementary Table  1). First, we used a panel of   31 indole derivatives from plants and microbes to identify a potent activator of AaegOR9, then we showed that AaegOR9 is narrowly tuned to skatole in the low nanomolar concentration range. Our findings suggest that Culicinae have developed a supersensitive skatole receptor that operates in water  where  this compound exhibits low solubility. The occurrence of two skatole receptors, each assigned to a different developmental stage indicates the central role of this odorant in the Ae. aegypti life cycle.

The deorphanization of AaegOR9: (i) provides a molecular target for future larval behavioral disruption studies;
(ii)improves our understanding of insect OR coding; 
(iii)raises questions on the possible ecological roles of mosquito indolergic receptors.


MATERIALS AND METHODS
Chemical Reagents
The chemicals (Supplementary Table 1) used for the deorphanization of AaegOR9 were obtained from Sigma- Aldrich (Milwaukee, WI, USA), ChemCruz (Dallas, TX, USA), Glentham Life Sciences (Corsham, UK), FluoroChem (Hadfield, UK), SL Moran (Jerusalem, Israel), Holland Moran (Yehun, Israel), Alfa Aesar (Ward Hill, MA, USA) and from the generous contribution of the Dr. Kolodkin-Gal Lab (Weizmann Institute of Science, Israel).

 

Two-Electrode Voltage Clamp of Xenopus
Oocytes Expressing ORs
The methodologies and protocols have been described in details elsewhere (Bohbot and Dickens, 2009). AaegOr9 and Aaeg- ORco cRNAs (Bohbot et al., 2011) were synthesized from linearized pSP64DV expression vectors using the mMESSAGE mMACHINEr SP6 kit (Life Technologies). Stage V-VII oocytes were harvested from Xenopus laevis females, mechanically separated, treated with collagenase (8 mg/mL, 30 min, 18?C) and rinsed in washing solution (96 mM NaCl, 2 mM KCl, 5 mM MgCl2 and 5 mM HEPES, pH 7.6). Oocytes were microinjected with 27.6 ng AaegOr9 and AaegORco cRNAs, incubated at 18?C for 3–4 days in ND96 solution (96  mM  NaCl, 2 mM KCl, 5 mM MgCl2, 0.8 mM CaCl2 and 5 mM using the two-microelectrode voltage-clamp technique. During recording sessions, the holding potential  was  maintained  at 80 mV using an OC-725C oocyte clamp (Warner Instruments, LLC, Hamden, CT, USA). Oocytes placed in a RC-3Z oocyte recording chamber (Warner Instruments, LLC, Hamden, CT, USA) were exposed to odorants for 8 s. Current was allowed to return to baseline between odorant applications. Data acquisition and concentration-response analyses were carried out with a Digidata 1550A and the pCLAMP10 software (Molecular Devices, Sunnyvale, CA,  USA),  and  analyzed using  GraphPad  Prism  7  (GraphPad  Software  Inc.,  La   Jolla, CA,  USA).  Stock  concentration  of  odorants  (10?2    M)   were dissolved in ringer solution containing 2% dimethyl sulfoxide (DMSO) in order to solubilize the hydrophobic indolic compounds.

 

Pharmacological Characterization
The response profile was established using multiple sessions, each including six compounds at a time and indole as an internal reference. The order in which these compounds were administered was reversed within a session to mitigate against any potential sequence effects between compounds (none were observed). All the response values were normalized to the indole reference in each recording session (Supplementary Figure 1).
For the establishment of the concentration-response curves, oocytes were exposed to increasing concentrations of indole, skatole and indole-3-carboxaldehyde (I3C; Supplementary Figure 2). Quantitative characterization of OR sensitivity was estimated using the averaged effective concentration at 50% of the maximal response (EC50) over the sample population. The data to establish the concentration response curve and EC50 of AaegOR10-skatole was extracted from a previous study (Bohbot and Dickens, 2012).

 

Phylogeny OR Intron-Exon Structure and Phylogeny
All the sequences used in our phylogenic analysis were obtained from the VectorBase and NCBI databases using AaegOr2/9/10  as query (for accession numbers, see Supplementary Table 3). DNA sequences for Toxorhynchites Or2 and Or10 can be accessed here: http://dx.doi.org/10.6084/m9.figshare.1092617. MAFFT version 7 (Nakamura et al., 2018) was used for multiple amino-acid sequence alignment. The phylogenic software IQ-TREE (Nguyen et al., 2015; Kalyaanamoorthy et al., 2017; Hoang et al., 2018) and the FigTree editor1 were used for building the mosquito indolergic receptor phylogenic tree based on the maximum likelihood method (Model: JC, UFbootstrap: 5,000). Using MAFFT (default parameters) and the Vectorbase database, we located the intron positions on the indolergic receptor genes.


RESULTS
AaegOR9 Is Narrowly Tuned to Skatole
Based on its larval expression (Bohbot et al., 2007) and functional characterization (Bohbot et al., 2011), we initially surmised that AaegOR9 would be narrowly tuned to a water- soluble indolic ligand. To test this hypothesis, we screened AaegOR9 with a panel of 31 indolic derivatives (Supplementary Table 1) exhibiting some degree of water solubility using the two electrodes voltage clamp of Xenopus laevis oocytes. We also included indole and skatole as references (Bohbot et al., 2011). The screen was carried out using a low odorant concentration (500 nM) in order to mitigate the caveats associated with high ligand concentrations, including receptor adaptation, antagonist effects and technical artifacts such as broad molecular receptive ranges (Bohbot and Pitts, 2015).


At this concentration, skatole was decisively  the  most potent ligand, eliciting responses five times higher than indole (Figure 1) confirming the hypothesis that the potential cognate ligand of AaegOR9 is an indole  derivative.  However,  this result contradicts our water-soluble ligand hypothesis. Indeed, skatole is about seven times less water soluble (0.5 mg/mL, ChemIDplus) than indole (3.56 mg/mL, ChemIDplus; Figure 1) and is considered rather insoluble in water as  a  result.
I3C, indole, 3-indole acetonitrile and methyl indole-3- carboxylate were the next most potent ligands suggesting that indole derivatives with a short side chain on position C3 can     fit into the binding pocket of AaegOR9. However, comparable small indolic compounds such as indole-3-carbinole or gramine were among the least potent ligands (Figure 1). Overall, the AaegOR9 response profile was narrow (kurtosis value of 17.75), especially considering that our odorant panel was restricted to indole derivatives.


AaegOR9 Is Supersensitive to Skatole
To characterize the pharmacological sensitivity of AaegOR9, we measured the amplitudes of the current responses of this receptor when exposed to increasing concentrations (100 pM to 10 μM) of skatole, indole and I3C (Figure 2A). Compound sensitivities were determined using the extrapolated EC50 values. This analysis confirmed that AaegOR9 is 176 times more sensitive to skatole than to indole. AaegOR9 is a significantly more sensitive skatole receptor (EC50 5 nM) than AaegOR10 (EC50 = 100 nM; Figure 2B). Although I3C and indole elicited comparable responses in our tuning curve experiment (Figure 1), their EC50 values were significantly different (Figure 2A),  underscoring the caveat of inferring receptor sensitivity based on tuning curves. Plotting the EC50 values of AaegOR9 against previously characterized OR-cognate odorant  pairs  (Supplementary Table 2) using our pharmacological platform (Bohbot and Pitts, 2015) reveals that the AaegOR9-skatole pair is the most sensitive indolergic OR (Figure 2C) and the most sensitive OR-ligand pair identified so far, outperforming the most sensitive pheromone receptor.

 

OR9 Is a Culicinae-Specific Gene Expansion
The conserved Or2, Or9, Or10 genes were initially identified from the An. gambiae and Ae. aegypti genomes (Hill et  al., 2002; Bohbot et al., 2007, 2011). These genes encode proteins with high amino-acid sequence identity considering the sequence divergence characteristic of this family (Figure 3A). We have extended our previous analysis (Bohbot et al., 2011) by including additional Anopheles species, Ae. albopictus and Toxorhynchites amboinensis. We confirm that the indolergic receptor clade is divided into the OR2 and OR10 subgroups indicating their ancestral origin (Figure 3A). Or9 emerged in the Culicinae lineage 52–54 mya (Arensburger et al., 2010), which includes Ae. albopictus and Cu. quinquefasciatus. There is no information regarding Or expression in To. amboinensis. We failed to identify any signature of other paralogs in An. gambiae and Ae. aegypti consistent with the hypothesis that the Or9-Or10 split occurred in Culicinae.
The greater similarity between AaegOR9 and AaegOR10 not only includes sequence conservation and amino-acid substitution rates but is also reflected by the patterns of conserved introns (Figure 3A). Both Culicinae Or10 and Or9 genes are missing introns 3 and 5. The absence of intron 5 is also a conserved feature within the Anophelinae Or10 clade. Or2,  Or9,  Or10  are  clustered  together  in  region  44  of  the   q arm of chromosome 2 in Ae. aegypti (Figure 3B). This region corresponds to region 34B of the orthologous chromosome 3R in An. gambiae, reflecting the extensive paracentric inversion events that occurred within chromosome segments between these two species (Severson et al., 2004; Arensburger et al., 2010).

 

DISCUSSION
We had originally reported AaegOR9 as a broadly tuned receptor sensitive to indole in the low micromolar  range  suggesting  that its cognate ligand, likely an indole derivative, remained to be identified (Bohbot et al., 2011). Here, we have shown that skatole selectively and reversibly activates AaegOR9 in the high picomolar (below 1 nM) to  low  nanomolar  (between  1  and  10 nM) concentration range consistent with the idea that it is the cognate odorant ligand for this receptor (Bohbot and Pitts, 2015).
Based on our analyzes and on the principle of parsimony,  we propose that Or2, Or9 and Or10 derive from two gene duplication events, one preceding the Anophelinae-Culicinae split that occurred 145–226 mya (Krzywinski et al., 2006; Reidenbach et al., 2009) and a  second  one  that  occurred  in the Culicinae lineage (Figure 4A). The most common recent ancestors of Or2 and Or10 were likely indole and skatole receptors since this function is still conserved in the two mosquito subfamilies (Bohbot et al., 2007). We hypothesize, that the original ancestral receptor was sensitive to an indolic compound, perhaps indole or skatole. Although it is unlikely, due to the nanomolar sensitivity of OR10 for skatole, it is conceivable  that  the  cognate  ligand  for  OR10  remains  to   be identified. It is remarkable that during their evolution, mosquitoes have retained the function of discriminating between close structural chemical analogs, differing by a methyl group on position C3.
While both AaegOR10 and AaegOR9 act as skatole receptors, they have diverged in function: larval AaegOR9 has a significantly higher sensitivity for this compound than adult AaegOR10. In addition, the expression pattern of AaegOr10 and AaegOr9 also diverged, allocating the role of skatole detection to the former  in adults and to the latter in larvae (Figure 4A). It is interesting that other insects, including Drosophila melanogaster larvae and adults detect the same cues using different ORs (Dweck et al., 2015). In our case, the role for this increased sensitivity and distinct expression patterns remain unclear.
Skatole seems to be playing a unique role  in  Ae.  aegypti. The increased sensitivity of  OR9  to  skatole  may  correspond to an evolutionary adaptation to the reduced water solubility    of this compound, conferring a fitness advantage at the larval stage. Being outperformed, larval Or10 expression may have been  relegated  to  the  adult  stage  where  skatole  can  occur   at much  higher  concentrations  due  to  its  high  volatility.  It  is interesting that both larva and adult An. gambiae detect skatole using the same receptor. Considering the differential sensitivity and developmental expression pattern of AaegOr9 and AaegOr10, we do not think this is a case of gene redundancy.
During the terrestrial stage, adult Ae. aegypti use olfaction   to locate nectar sources, suitable oviposition sites and animal hosts using  about  80  Or  genes.  The  aquatic  larva  has  a more limited range of behaviors (mostly feeding and escape behaviors), occupy one type of habitat and express 23 Or genes of which 15 are larval specific. Based on our study, it will be interesting to explore whether other larval-specific receptors have evolved enhanced sensitivity to poorly soluble volatile organic compounds.
Larvae mainly graze on biofilm  (fungi,  bacteria,  algae),  dead larvae (Kinney et al., 2014) and other decomposing organic matter including plant  materials,  which  are  sources  of indolic compounds (Figure 4B). The exact roles of indole    in adult mosquitoes, while traditionally ascribed to oviposition (Blackwell and Johnson, 2000), is much more complex than previously thought as male adult mosquitoes, as well as larvae, have relied on these compounds in the last 200 millions  of  years of evolution. These findings underscore the conserved and different roles indoles assume in the life histories of mosquitoes. It now remains to untangle the physiological, behavioral and ecological roles of these interesting compounds in the life of these insects.

DATA AVAILABILITY
The datasets generated for this study can be found in Figshare, http://dx.doi.org/10.6084/m9.figshare.1092617.

ETHICS STATEMENT
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed (NIH approval number: OPRR-A01-5011).

AUTHOR CONTRIBUTIONS
JB designed and wrote the manuscript. EY provided technical support. DR carried out the experiment, analyzed the data and participated in the writing of the manuscript.

FUNDING
This work was supported by the Israel Science Foundation (grant no. 1990/16).


ACKNOWLEDGMENTS
We  thank  Dr.  Ronald  J.  Pitts  for  his  critical  reading  of     the  manuscript,  Dr.  Osnat  Malka   for   her   insights   and   Dr. Diego Santos-Garcia for his expertise in computational biology.

ANGENE is pledged to providing quality specialty chemicals for use in research and development and commercial manufacturing:

CAS No. 102360-09-8

Ethanone, 1-(1,5-dihydroxy-2-naphthalenyl)-

Catalog No.:AG0007A4 MDL No.:

MF:C12H10O3 MW:202.2060

CAS No. 102360-10-1

Ethanone, 1,1'-(1,5-dihydroxy-2,6-naphthalenediyl)bis-

Catalog No.:AG0007A3 MDL No.:

MF:C14H12O4 MW:244.2427

CAS No. 102362-00-5

4-Cyano-3-methoxybenzoic acid

Catalog No.:AG0007A2 MDL No.:MFCD18203531

MF:C9H7NO3 MW:177.1568

CAS No. 102362-02-7

Benzonitrile, 4-acetyl-2-methoxy-

Catalog No.:AG0007A1 MDL No.:

MF:C10H9NO2 MW:175.1840

CAS No. 102362-14-1

Imidazo[1,2-a]pyrazine, 2-[2-methoxy-4-(methylsulfinyl)phenyl]-

Catalog No.:AG0007A0 MDL No.:

MF:C14H13N3O2S MW:287.3369

CAS No. 102362-49-2

Cholan-24-oic acid, 3,7,12-trihydroxy-7-methyl-, (3α,5β,7α,12α)-

Catalog No.:AG00079Z MDL No.:

MF:C25H42O5 MW:422.5980

CAS No. 102362-80-1

1-Propanesulfonic acid, 3-[(3-hydroxyphenyl)propylamino]-

Catalog No.:AG00079Y MDL No.:

MF:C12H19NO4S MW:273.3486

CAS No. 102362-98-1

1,2-Benzisothiazole, 2,3-dihydro-3,3-dimethyl-, 1,1-dioxide

Catalog No.:AG00079X MDL No.:

MF:C9H11NO2S MW:197.2541

CAS No. 102363-16-6

1-Azetidinecarboxamide, 3-[4-(trifluoromethyl)phenoxy]-

Catalog No.:AG00079W MDL No.:

MF:C11H11F3N2O2 MW:260.2124

CAS No. 102363-19-9

3,7,11,17-Tetraazabicyclo[11.3.1]heptadeca-1(17),13,15-triene

Catalog No.:AG00079V MDL No.:

MF:C13H22N4 MW:234.3406

CAS No. 102363-24-6

Cyclohepta[b]pyrrole, 2-hydrazinyl-

Catalog No.:AG00079U MDL No.:

MF:C9H9N3 MW:159.1879

CAS No. 102363-64-4

1-Oxa-4-thiaspiro[4.5]decane, 9-methyl-6-(1-methylethyl)-

Catalog No.:AG00079T MDL No.:

MF:C12H22OS MW:214.3675

CAS No. 102363-66-6

1,4-Benzoxathiin, 2,3-dihydro-6-methyl-

Catalog No.:AG00079S MDL No.:

MF:C9H10OS MW:166.2401

CAS No. 102364-09-0

Benzoic acid, 4-(decyloxy)-, 4-(2-ethoxypropoxy)phenyl ester

Catalog No.:AG00079R MDL No.:

MF:C28H40O5 MW:456.6142

CAS No. 102367-26-0

Thiocyanic acid, 2-bromo-2-propen-1-yl ester

Catalog No.:AG0007AN MDL No.:

MF:C4H4BrNS MW:178.0503

CAS No. 102367-27-1

Thiocyanic acid, 3-bromo-2-propen-1-yl ester

Catalog No.:AG0007AM MDL No.:

MF:C4H4BrNS MW:178.0503

CAS No. 102367-28-2

Thiocyanic acid, 2,3-dibromo-2-propen-1-yl ester

Catalog No.:AG0007AL MDL No.:

MF:C4H3Br2NS MW:256.9463

CAS No. 102367-29-3

Thiocyanic acid, 2-(octahydro-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)ethyl ester

Catalog No.:AG0007AK MDL No.:

MF:C11H12N2O3S MW:252.2896

CAS No. 102367-56-6

1H-Purine-2,6-dione, 7-[(4,4-dimethyl-4H-1,3-benzothiazin-2-yl)methyl]-3,7-dihydro-1,3-dimethyl-

Catalog No.:AG0007AJ MDL No.:

MF:C18H19N5O2S MW:369.4408

CAS No. 102367-91-9

Benzene, 3-methyl-1,2,4,5-tetranitro-

Catalog No.:AG0007AI MDL No.:

MF:C7H4N4O8 MW:272.1287

CAS No. 1023674-80-7

Anthracene, 9-(3-bromophenyl)-10-phenyl-

Catalog No.:AG0007A9 MDL No.:MFCD28100940

MF:C26H17Br MW:409.3172

CAS No. 102368-13-8

2(1H)-Pyridinone, 1,1'-carbonothioylbis-

Catalog No.:AG0007AH MDL No.:MFCD00075238

MF:C11H8N2O2S MW:232.2584

CAS No. 102368-18-3

1,3-Dioxane-2-thione, 4,4,6-trimethyl-

Catalog No.:AG0007AG MDL No.:

MF:C7H12O2S MW:160.2340

CAS No. 102369-06-2

Oxiranecarboxaldehyde, 3-heptyl-, (2R,3S)-rel- (9CI)

Catalog No.:AG0007AF MDL No.:

MF:C10H18O2 MW:170.2487

CAS No. 102369-67-5

Cyclohexanemethanol, 3,3-dimethyl-

Catalog No.:AG0007AE MDL No.:MFCD21324307

MF:C9H18O MW:142.2386

CAS No. 10237-16-8

1-Decanamine, N,N-dimethyl-, hydrochloride (1:1)

Catalog No.:AG0007AT MDL No.:

MF:C12H28ClN MW:221.8104

CAS No. 10237-22-6

Phosphine, trimethyl-, hydrochloride (9CI)

Catalog No.:AG0007AS MDL No.:

MF:C3H10ClP MW:112.5383

CAS No. 10237-24-8

Benzenaminium, N,N,N-triphenyl-, chloride (1:1)

Catalog No.:AG0007AR MDL No.:

MF:C24H20ClN MW:357.8753

CAS No. 10237-48-6

1,2,4-Triazine-3,5(2H,4H)-dione, 6-(2-propen-1-ylthio)-

Catalog No.:AG0007AQ MDL No.:

MF:C6H7N3O2S MW:185.2037

CAS No. 10237-70-4

2-Butenedioic acid (2Z)-, potassium salt (1:?)

Catalog No.:AG0007AP MDL No.:MFCD00152764

MF:C4H2K2O4 MW:192.2529

CAS No. 10237-77-1

Pentanoic acid, 3-hydroxy-

Catalog No.:AG0007AO MDL No.:MFCD07778468

MF:C5H10O3 MW:118.1311

CAS No. 1023714-94-4

Naphthalene, 7-iodo-1,2,6-trimethoxy-

Catalog No.:AG0007A8 MDL No.:

MF:C13H13IO3 MW:344.1450

CAS No. 102372-32-7

Pyrrolidine, 1-butyl-3-(diphenylmethoxy)-

Catalog No.:AG0007AD MDL No.:

MF:C21H27NO MW:309.4452

CAS No. 1023732-78-6

Imidazo[2,1-b]thiazole-3-methanol, 6-(2-aminophenyl)-

Catalog No.:AG0007A7 MDL No.:

MF:C12H11N3OS MW:245.3002

CAS No. 1023742-13-3

Hydroxylamine, O-[2-(1,1-dimethylethoxy)ethyl]-

Catalog No.:AG0007A6 MDL No.:MFCD09951924

MF:C6H15NO2 MW:133.1888

CAS No. 102375-54-2

2-Propenoic acid, 2-cyano-, hexadecyl ester

Catalog No.:AG0007AC MDL No.:

MF:C20H35NO2 MW:321.4974

CAS No. 1023758-31-7

4(1H)-Pyrimidinethione, 5-amino-6-chloro-2-methyl-

Catalog No.:AG0007A5 MDL No.:

MF:C5H6ClN3S MW:175.6392

CAS No. 102376-29-4

Octadecanoyl chloride, 12-(acetyloxy)-

Catalog No.:AG0007AB MDL No.:

MF:C20H37ClO3 MW:360.9590

CAS No. 102376-75-0

Piperidine, 1-(1-cyclohexyl-4-phenylbutyl)-

Catalog No.:AG0007AA MDL No.:

MF:C21H33N MW:299.4934

CAS No. 1023794-80-0

Benzeneacetaldehyde, 5-fluoro-2-methyl-

Catalog No.:AG0007BB MDL No.:MFCD11110133

MF:C9H9FO MW:152.1656

CAS No. 10238-27-4

β-D-Xylopyranoside, 2-nitrophenyl

Catalog No.:AG0007BH MDL No.:MFCD00047515

MF:C11H13NO7 MW:271.2234

CAS No. 10238-28-5

α-D-Xylopyranoside, 4-nitrophenyl

Catalog No.:AG0007BG MDL No.:MFCD00067649

MF:C11H13NO7 MW:271.2234

CAS No. 1023810-85-6

Carbamic acid, N-4-piperidinyl-, 2-propen-1-yl ester

Catalog No.:AG0007BA MDL No.:MFCD04115037

MF:C9H16N2O2 MW:184.2355

CAS No. 1023812-18-1

2(1H)-Pyrimidinone, 5,6-dibromo-

Catalog No.:AG0007B9 MDL No.:MFCD23701553

MF:C4H2Br2N2O MW:253.8795

CAS No. 1023812-90-9

4-Pyridinecarboxaldehyde, 2-(1,1-dimethylethyl)-

Catalog No.:AG0007B8 MDL No.:MFCD09881169

MF:C10H13NO MW:163.2163

CAS No. 1023813-21-9

2-Pyrazinecarboxamide, 3,6-dichloro-

Catalog No.:AG0007B7 MDL No.:MFCD09881212

MF:C5H3Cl2N3O MW:192.0028

CAS No. 1023813-80-0

1,8-Naphthyridine, 6-bromo-1,2,3,4-tetrahydro-

Catalog No.:AG0007B6 MDL No.:MFCD09881254

MF:C8H9BrN2 MW:213.0745

CAS No. 1023814-35-8

3-Pyridinecarboxaldehyde, 2-amino-5-methyl-

Catalog No.:AG0007B5 MDL No.:MFCD09754122

MF:C7H8N2O MW:136.1512

CAS No. 1023814-75-6

3-Furanmethanamine, 2,4-dimethyl-

Catalog No.:AG0007B4 MDL No.:MFCD09754199

MF:C7H11NO MW:125.1683

CAS No. 1023815-07-7

pyrido[4,3-d]pyrimidin-4-amine

Catalog No.:AG0007B3 MDL No.:

MF:C7H6N4 MW:146.1493

CAS No. 1023815-26-0

3H-Imidazo[4,5-b]pyridin-6-ol

Catalog No.:AG0007B2 MDL No.:MFCD09881287

MF:C6H5N3O MW:135.1234

CAS No. 1023815-33-9

4-Thiazolamine, 2-[4-(methylsulfonyl)-1-piperazinyl]-

Catalog No.:AG0007B1 MDL No.:MFCD26127725

MF:C8H14N4O2S2 MW:262.3524

CAS No. 1023815-74-8

1,1-Cyclobutanedimethanol, 3,3-dimethoxy-, 1,1-bis(4-methylbenzenesulfonate)

Catalog No.:AG0007B0 MDL No.:

MF:C22H28O8S2 MW:484.5829

CAS No. 1023815-83-9

Methanediamine, N,N-dimethyl-1-phenyl-

Catalog No.:AG0007AZ MDL No.:

MF:C9H14N2 MW:150.2209

CAS No. 1023815-99-7

2-Quinolinecarboxylic acid, 8-(trifluoromethyl)-

Catalog No.:AG0007AY MDL No.:

MF:C11H6F3NO2 MW:241.1660

CAS No. 1023817-02-8

Pyrido[2,3-b]pyrazine, 8-methyl-

Catalog No.:AG0007AX MDL No.:MFCD09881189

MF:C8H7N3 MW:145.1613

CAS No. 1023817-19-7

Pyrrolo[3,4-c]pyrrole, 1,2,3,5-tetrahydro-2-(phenylmethyl)-

Catalog No.:AG0007AW MDL No.:MFCD09881386

MF:C13H14N2 MW:198.2637

CAS No. 1023817-89-1

1H-Pyrrolo[3,2-b]pyridine-3-carboxaldehyde, 7-methyl-

Catalog No.:AG0007AV MDL No.:

MF:C9H8N2O MW:160.1726

CAS No. 1023818-09-8

4-Pyrimidinamine, 6-(2,6-dimethyl-4-morpholinyl)-2-methyl-

Catalog No.:AG0007AU MDL No.:MFCD09880707

MF:C11H18N4O MW:222.2868

CAS No. 102386-90-3

Cyclohexenecarboxaldehyde, methyl- (9CI)

Catalog No.:AG0007BF MDL No.:MFCD24673706

MF:C8H12O MW:124.1803

CAS No. 102387-17-7

Benzamide, 4-cyano-N-(4,4'-dinitro[1,1'-biphenyl]-2-yl)-

Catalog No.:AG0007BE MDL No.:

MF:C20H12N4O5 MW:388.3331

CAS No. 102387-48-4

Acetamide, N-[5-chloro-3-[[4-(diethylamino)-2-methylphenyl]imino]-4-methyl-6-oxo-1,4-cyclohexadien-1-yl]-

Catalog No.:AG0007BD MDL No.:MFCD19443390

MF:C20H24ClN3O2 MW:373.8765

CAS No. 102388-00-1

1H-Pyrazole, 1-(chloromethyl)-3-nitro-

Catalog No.:AG0007BC MDL No.:MFCD04968625

MF:C4H4ClN3O2 MW:161.5465

CAS No. 1023888-29-0

2-Pyrimidinamine, 4-(3-azetidinyl)-N-ethyl-

Catalog No.:AG0007BI MDL No.:MFCD18073440

MF:C9H14N4 MW:178.2343

CAS No. 102389-74-2

Diazene, (4-butylphenyl)[4-(hexyloxy)phenyl]-, (1E)- (9CI)

Catalog No.:AG0007C4 MDL No.:

MF:C22H30N2O MW:338.4864

CAS No. 102389-90-2

3,4-Pyrrolidinedicarboxylic acid, 1-methyl-, 3,4-dimethyl ester, (3R,4S)-rel-

Catalog No.:AG0007C3 MDL No.:MFCD11845731

MF:C9H15NO4 MW:201.2197

CAS No. 10239-34-6

1,3-Propanediamine, N1,N3-bis(phenylmethyl)-

Catalog No.:AG0007C6 MDL No.:MFCD06661418

MF:C17H22N2 MW:254.3700

CAS No. 10239-86-8

Acenaphthylene, 4,7-bis(1,1-dimethylethyl)-1,2-dihydro-

Catalog No.:AG0007C5 MDL No.:MFCD00102167

MF:C20H26 MW:266.4204

CAS No. 102390-10-3

2-Butenoic acid, 4-[[dioctyl[(1-oxododecyl)oxy]stannyl]oxy]-4-oxo-, (Z)- (9CI)

Catalog No.:AG0007C2 MDL No.:

MF:C32H60O6Sn MW:659.5162

CAS No. 102390-63-6

1H-Imidazole, 5-(2,2-diphenylethyl)-

Catalog No.:AG0007C1 MDL No.:

MF:C17H16N2 MW:248.3223

CAS No. 102390-98-7

Silane, triethoxy(3,3,4,4,5,5,6,6,6-nonafluorohexyl)-

Catalog No.:AG0007C0 MDL No.:MFCD09954454

MF:C12H19F9O3Si MW:410.3486

CAS No. 102391-02-6

1,1,2-Ethenetricarbonitrile, 2-[4-(butylethylamino)phenyl]-

Catalog No.:AG0007BZ MDL No.:

MF:C17H18N4 MW:278.3516

CAS No. 102391-96-8

Methanone, [4-(3-aminopropyl)-1-piperazinyl]phenyl-

Catalog No.:AG0007BY MDL No.:MFCD10016029

MF:C14H21N3O MW:247.3360

CAS No. 102391-98-0

Methanone, (4-fluorophenyl)-1-piperazinyl-

Catalog No.:AG0007BX MDL No.:MFCD01829194

MF:C11H13FN2O MW:208.2321

CAS No. 102392-07-4

Piperazine, 1-(5-fluoro-2-methoxyphenyl)-

Catalog No.:AG0007BW MDL No.:MFCD11872760

MF:C11H15FN2O MW:210.2480

CAS No. 102392-11-0

Piperazine, 1-(4-fluoro-2-methoxyphenyl)-

Catalog No.:AG0007BV MDL No.:MFCD11872815

MF:C11H15FN2O MW:210.2480

CAS No. 102392-27-8

2H-1-Benzopyran-3-carboxylic acid, 7-[3-[4-[(4-chlorophenyl)methyl]-1-piperazinyl]propoxy]-4-methyl-2-oxo-

Catalog No.:AG0007BU MDL No.:

MF:C25H27ClN2O5 MW:470.9453

CAS No. 102392-50-7

Spiro[5.5]undeca-1,4,8-trien-3-one, 2,4-bis(1-methylethyl)-

Catalog No.:AG0007BT MDL No.:

MF:C17H24O MW:244.3719

CAS No. 102392-83-6

1-Pyrrolidinecarboximidamide, hydriodide (1:1)

Catalog No.:AG0007BS MDL No.:MFCD00114285

MF:C5H12IN3 MW:241.0734

CAS No. 102393-47-5

Cyclohexanecarbonyl chloride, 3,3-dimethyl-

Catalog No.:AG0007BR MDL No.:

MF:C9H15ClO MW:174.6678

CAS No. 102393-82-8

Quinazoline, 6-bromo-2,4-dichloro-

Catalog No.:AG0007BQ MDL No.:MFCD09744007

MF:C8H3BrCl2N2 MW:277.9328

CAS No. 102394-28-5

Benzoic acid, 4-hydroxy-2-[[[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]amino]sulfonyl]-, methyl ester

Catalog No.:AG0007BP MDL No.:

MF:C14H15N5O7S MW:397.3632

CAS No. 102394-31-0

6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-

Catalog No.:AG0007BO MDL No.:

MF:C24H31N5O2 MW:421.5352

CAS No. 102394-34-3

Benzoxazole, 5-chloro-2-(phenylmethyl)-

Catalog No.:AG0007BN MDL No.:

MF:C14H10ClNO MW:243.6883

CAS No. 102394-37-6

Benzoxazole, 2-[(4-bromophenyl)methyl]-5-chloro-

Catalog No.:AG0007BM MDL No.:

MF:C14H9BrClNO MW:322.5844

CAS No. 102395-13-1

Tricyclo[3.3.1.13,7]decan-1-amine, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

Catalog No.:AG0007BL MDL No.:

MF:C16H25NO7 MW:343.3722

CAS No. 102395-33-5

1,3,8-Triazaspiro[4.5]decane-2,4-dione, 8-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-1,3-bis(1-methylethyl)-

Catalog No.:AG0007BK MDL No.:

MF:C22H31N3O4 MW:401.4992

CAS No. 102395-43-7

1,3,8-Triazaspiro[4.5]decan-4-one, 1-phenyl-3-(2-propen-1-yl)-8-[3-[2-(2-thienyl)-1,3-dioxolan-2-yl]propyl]-, (2E)-2-butenedioate (1:1)

Catalog No.:AG0007BJ MDL No.:

MF:C30H37N3O7S MW:583.6957

CAS No. 102395-44-8

1,3,8-Triazaspiro[4.5]decan-4-one, 8-[1-(2,3-dihydro-1,4-benzodioxin-2-yl)ethyl]-3-methyl-1-phenyl-

Catalog No.:AG0007CO MDL No.:

MF:C24H29N3O3 MW:407.5054

CAS No. 102395-47-1

1,3,8-Triazaspiro[4.5]decan-4-one, 8-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-3-ethyl-1-phenyl-

Catalog No.:AG0007CN MDL No.:

MF:C24H29N3O3 MW:407.5054

CAS No. 102395-58-4

1,3,8-Triazaspiro[4.5]decan-4-one, 8-[(8-ethoxy-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-3-methyl-1-phenyl-

Catalog No.:AG0007CM MDL No.:

MF:C25H31N3O4 MW:437.5313

CAS No. 102395-59-5

1,3,8-Triazaspiro[4.5]decan-4-one, 8-[(8-ethoxy-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-1-phenyl-

Catalog No.:AG0007CL MDL No.:

MF:C24H29N3O4 MW:423.5048

CAS No. 102395-67-5

4-Piperidinecarboxylic acid, 1-methyl-, diphenylmethyl ester

Catalog No.:AG0007CK MDL No.:

MF:C20H23NO2 MW:309.4021

CAS No. 102395-71-1

4-Piperidinecarboxylic acid, 1-[[(4-methylphenyl)amino]carbonyl]-4-phenyl-, ethyl ester

Catalog No.:AG0007CJ MDL No.:

MF:C22H26N2O3 MW:366.4534

CAS No. 102395-75-5

α-D-Glucopyranosiduronic acid, (3β,20β)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-β-D-glucopyranuronosyl-, compd. with 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline (1:1) (9CI)

Catalog No.:AG0007CI MDL No.:

MF:C63H85NO19 MW:1160.3443

CAS No. 102395-77-7

Isoquinoline, 2-cyclopropyl-1,2,3,4-tetrahydro-, hydrochloride (1:1)

Catalog No.:AG0007CH MDL No.:

MF:C12H16ClN MW:209.7151

CAS No. 102395-78-8

Isoquinoline, 1,2,3,4-tetrahydro-6,7-dimethoxy-2-[2-(1-piperidinyl)ethyl]-, hydrochloride (1:2)

Catalog No.:AG0007CG MDL No.:

MF:C18H30Cl2N2O2 MW:377.3490

CAS No. 102395-94-8

1-Butanamine, 3-methyl-, sulfate (2:1)

Catalog No.:AG0007CF MDL No.:

MF:C10H28N2O4S MW:272.4053

CAS No. 102395-95-9

Arsine, (4-methylphenyl)oxo-

Catalog No.:AG0007CE MDL No.:

MF:C7H7AsO MW:182.0515

CAS No. 102396-21-4

1(3H)-Isobenzofuranone, 4-acetyl-3-(acetyloxy)-5-[(1S)-1,3,3-trimethylcyclohexyl]-, (3S)-

Catalog No.:AG0007CD MDL No.:

MF:C21H26O5 MW:358.4281

CAS No. 102396-24-7

Cyclo[(3R)-3-(4-hydroxyphenyl)-β-alanyl-(2S,4E,6R,8S)-8-hydroxy-2,4,6-trimethyl-4-nonenoyl-L-alanyl-2-bromo-N-methyl-D-tryptophyl]

Catalog No.:AG0007CC MDL No.:MFCD00873735

MF:C36H45BrN4O6 MW:709.6697

CAS No. 102396-29-2

4-Pyrimidinamine, 6-chloro-5-methyl-N-(1-methylethyl)-2-(1-piperazinyl)-

Catalog No.:AG0007CB MDL No.:

MF:C12H20ClN5 MW:269.7737

CAS No. 1023964-84-2

1-Piperazinecarboxylic acid, 2-(1-methylethyl)-, phenylmethyl ester, (2S)-

Catalog No.:AG0007C7 MDL No.:MFCD09954324

MF:C15H22N2O2 MW:262.3474

CAS No. 102397-36-4

Benzenaminium, N-methylidyne-

Catalog No.:AG0007CA MDL No.:

MF:C7H6N+ MW:104.1292

CAS No. 102397-76-2

2H-Thiazolo[5,4-g][1,4]benzoxazine (9CI)

Catalog No.:AG0007C9 MDL No.:

MF:C9H6N2OS MW:190.2217

CAS No. 102397-77-3

2,8-Methanopyrido[3,4-b]pyrazine (9CI)

Catalog No.:AG0007C8 MDL No.:

MF:C8H5N3 MW:143.1454

CAS No. 1024-07-3

1,3,2,4-Dithiadiphosphetane, 2,4-diphenyl-, 2,4-disulfide

Catalog No.:AG0007CV MDL No.:

MF:C12H10P2S4 MW:344.4153

CAS No. 1024-11-9

4-Piperidinecarboxamide, 4-(methylamino)-1-(phenylmethyl)-

Catalog No.:AG0007CU MDL No.:

MF:C14H21N3O MW:247.3360

CAS No. 1024-16-4

4-Piperidinecarbonitrile, 4-(ethylamino)-1-(phenylmethyl)-

Catalog No.:AG0007CT MDL No.:

MF:C15H21N3 MW:243.3473

CAS No. 1024-30-2

Morpholine, 4-[(4-nitrophenyl)sulfonyl]-

Catalog No.:AG0007CS MDL No.:MFCD00277217

MF:C10H12N2O5S MW:272.2777

CAS No. 1024-37-9

Benzenesulfonamide, 4-amino-N-(4-iodo-5-methyl-3-isoxazolyl)-

Catalog No.:AG0007CR MDL No.:

MF:C10H10IN3O3S MW:379.1742

CAS No. 1024-38-0

Benzenesulfonamide, N-(2-bromophenyl)-4-methyl-

Catalog No.:AG0007CQ MDL No.:MFCD00192669

MF:C13H12BrNO2S MW:326.2089

CAS No. 1024-41-5

Benzenesulfonic acid, 4-methyl-, phenylmethyl ester

Catalog No.:AG0007CP MDL No.:MFCD01318299

MF:C14H14O3S MW:262.3242

CAS No. 1024-47-1

Naphthalene, 1,4-bis(trimethylsilyl)-

Catalog No.:AG0007DI MDL No.:

MF:C16H24Si2 MW:272.5328

CAS No. 1024-48-2

Naphthalene, 1,4-bis(dichloromethylsilyl)-

Catalog No.:AG0007DH MDL No.:

MF:C12H12Cl4Si2 MW:354.2067

CAS No. 1024-49-3

Naphthalene, 1,4-bis(trichlorosilyl)-

Catalog No.:AG0007DG MDL No.:

MF:C10H6Cl6Si2 MW:395.0436

CAS No. 1024-51-7

Sulfone, dichloromethyl 2,4-dinitrophenyl (7CI,8CI)

Catalog No.:AG0007DF MDL No.:

MF:C7H4Cl2N2O6S MW:315.0875

CAS No. 1024-58-4

Urea, N-phenyl-N,N'-bis(trimethylsilyl)-

Catalog No.:AG0007DE MDL No.:

MF:C13H24N2OSi2 MW:280.5135

CAS No. 1024-60-8

1,4-Naphthalenedione, 2,3,5,6,7,8-hexafluoro-

Catalog No.:AG0007DD MDL No.:

MF:C10F6O2 MW:266.0962

CAS No. 1024-65-3

1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(3-methylbutyl)-

Catalog No.:AG0007DC MDL No.:

MF:C12H18N4O2 MW:250.2969

CAS No. 1024-94-8

2,2'-Bipyridine, 3,3'-dinitro-

Catalog No.:AG0007DB MDL No.:

MF:C10H6N4O4 MW:246.1790

CAS No. 1024-99-3

Uridine, 5-iodo-

Catalog No.:AG0007DA MDL No.:MFCD00006532

MF:C9H11IN2O6 MW:370.0979

CAS No. 10240-08-1

1-Naphthalenol, 4-methyl-

Catalog No.:AG0007D9 MDL No.:MFCD00060344

MF:C11H10O MW:158.1965

CAS No. 10240-10-5

1-Naphthalenol, 4-(1-methylethyl)-

Catalog No.:AG0007D8 MDL No.:

MF:C13H14O MW:186.2497

CAS No. 102400-38-4

Copper, bis[1,1-dicyano-2-imino-2-(1H-pyrazol-1-yl)ethyl]- (9CI)

Catalog No.:AG0007D7 MDL No.:

MF:C14H8CuN10 MW:379.8263

CAS No. 1024003-57-3

3-Pyridinemethanamine, 2-(1-azetidinyl)-

Catalog No.:AG0007D1 MDL No.:

MF:C9H13N3 MW:163.2196

CAS No. 1024006-03-8

Hydrazine, (2,4,5-trifluorophenyl)-, hydrochloride (1:1)

Catalog No.:AG0007D0 MDL No.:MFCD22578527

MF:C6H6ClF3N2 MW:198.5734

CAS No. 1024010-90-9

2,5-Diazabicyclo[2.2.1]heptane, 2-(phenylmethyl)-, hydrochloride (1:2), (1R,4R)-

Catalog No.:AG0007CZ MDL No.:MFCD08667860

MF:C12H18Cl2N2 MW:261.1907

CAS No. 1024015-36-8

CarbaMic acid, N-[cis-4-[[(4-Methylphenyl)sulfonyl]oxy]cyclohexyl]-, 1,1-diMethylethyl ester

Catalog No.:AG0007CY MDL No.:

MF:C18H27NO5S MW:369.4757

CAS No. 1024017-53-5

Boronic acid, B-[4-[(1,1-dimethylethoxy)methyl]phenyl]-

Catalog No.:AG0007CX MDL No.:MFCD03701685

MF:C11H17BO3 MW:208.0619

CAS No. 102402-46-0

Cyclohexanecarboxylic acid, 2-amino-2-phosphono-

Catalog No.:AG0007D6 MDL No.:

MF:C7H14NO5P MW:223.1635

CAS No. 102402-47-1

2H-1-Benzopyran-2-one, 7-[3-[4-[(4-chlorophenyl)methyl]-1-piperazinyl]propoxy]-3-(hydroxymethyl)-4-methyl-

Catalog No.:AG0007D5 MDL No.:

MF:C25H29ClN2O4 MW:456.9618

CAS No. 102402-71-1

Thiophene, 2,2'-[1,2-bis(methylene)-1,2-ethanediyl]bis- (9CI)

Catalog No.:AG0007D4 MDL No.:

MF:C12H10S2 MW:218.3378

CAS No. 102402-80-2

Stannane, (3,3-dimethoxypropyl)trimethyl-

Catalog No.:AG0007D3 MDL No.:MFCD03425840

MF:C8H20O2Sn MW:266.9442

CAS No. 102402-84-6

2,4-Pentanedione, 3-tricyclo[3.3.1.13,7]dec-1-yl-

Catalog No.:AG0007D2 MDL No.:MFCD02258891

MF:C15H22O2 MW:234.3340

CAS No. 1024033-43-9

3-Piperidineacetic acid, 1-[5-[(cyclohexylamino)carbonyl]-6-(propylthio)-2-pyridinyl]-, (3S)-

Catalog No.:AG0007CW MDL No.:

MF:C22H33N3O3S MW:419.5807

CAS No. 1024036-99-4

3-Pyridinecarboxamide, 6-chloro-N-cyclohexyl-2-(propylthio)-

Catalog No.:AG0007DN MDL No.:

MF:C15H21ClN2OS MW:312.8580

CAS No. 1024038-31-0

3-Pyrrolidineacetic acid, methyl ester, hydrochloride (1:1), (3R)-

Catalog No.:AG0007DM MDL No.:MFCD22377963

MF:C7H14ClNO2 MW:179.6446

CAS No. 1024038-33-2

3-Pyrrolidineacetic acid, methyl ester, hydrochloride (1:1), (3S)-

Catalog No.:AG0007DL MDL No.:MFCD22377962

MF:C7H14ClNO2 MW:179.6446

CAS No. 1024038-72-9

3-Azabicyclo[3.1.0]hexane-6-carboxylic acid, methyl ester, (1α,5α,6α)-

Catalog No.:AG0007DK MDL No.:MFCD19160626

MF:C7H12ClNO2 MW:177.6287

CAS No. 102405-44-7

Benzoxazole, 5-chloro-6-nitro-2-phenyl-

Catalog No.:AG0007E2 MDL No.:

MF:C13H7ClN2O3 MW:274.6593

CAS No. 102405-54-9

Benzoxazole, 5-chloro-2-(1,1-dimethylethyl)-6-nitro-

Catalog No.:AG0007E1 MDL No.:

MF:C11H11ClN2O3 MW:254.6696

CAS No. 102405-96-9

Benzoxazole, 2-(1,1-dimethylethyl)-6-nitro-5-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-

Catalog No.:AG0007E0 MDL No.:

MF:C25H32N2O4 MW:424.5326

CAS No. 1024054-68-9

4-Benzothiazolecarboxylic acid, 2-amino-, methyl ester

Catalog No.:AG0007DJ MDL No.:MFCD04971761

MF:C9H8N2O2S MW:208.2370

CAS No. 102407-96-5

Propanoic acid, 2-methyl-, 2-fluoro-2,2-dinitroethyl ester

Catalog No.:AG0007DZ MDL No.:

MF:C6H9FN2O6 MW:224.1439

CAS No. 102407-97-6

Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl ester

Catalog No.:AG0007DY MDL No.:

MF:C17H19Cl2NO4 MW:372.2431

CAS No. 102408-25-3

1H-Imidazo[4,5-f]quinolin-2-amine, 1-methyl-

Catalog No.:AG0007DX MDL No.:

MF:C11H10N4 MW:198.2239

CAS No. 102408-26-4

3H-Imidazo[4,5-f]quinolin-2-amine, N,3-dimethyl-

Catalog No.:AG0007DW MDL No.:

MF:C12H12N4 MW:212.2505

CAS No. 102408-27-5

3H-Imidazo[4,5-f]quinolin-2-amine, N,N,3-trimethyl-

Catalog No.:AG0007DV MDL No.:

MF:C13H14N4 MW:226.2771

CAS No. 102408-28-6

1H-Imidazo[4,5-f]quinolin-2-amine, N,1-dimethyl-

Catalog No.:AG0007DU MDL No.:

MF:C12H12N4 MW:212.2505

CAS No. 102408-29-7

1H-Imidazo[4,5-f]quinolin-2-amine, N,N,1-trimethyl-

Catalog No.:AG0007DT MDL No.:

MF:C13H14N4 MW:226.2771

CAS No. 102408-31-1

1H-Naphth[2,3-d]imidazol-2-amine

Catalog No.:AG0007DS MDL No.:MFCD01712432

MF:C11H9N3 MW:183.2093

CAS No. 102408-53-7

Phenol, 4-(5-nonyl-2-pyrimidinyl)-

Catalog No.:AG0007DR MDL No.:

MF:C19H26N2O MW:298.4225

CAS No. 102408-54-8

Phenol, 4-(5-decyl-2-pyrimidinyl)-

Catalog No.:AG0007DQ MDL No.:

MF:C20H28N2O MW:312.4491

CAS No. 102409-43-8

1H-Indole, 1-[2-(hexyloxy)ethyl]-2,3-dihydro-3,3-dimethyl-2-methylene-

Catalog No.:AG0007DP MDL No.:

MF:C19H29NO MW:287.4397

CAS No. 102409-92-7

3,9-Epoxy-3H-azirino[2,3-c][1]benzazocine-5-carboxaldehyde, 1-acetyl-9-(acetyloxy)-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,9,9a-hexahydro-7-methoxy-

Catalog No.:AG0007DO MDL No.:

MF:C19H21N3O8 MW:419.3853

CAS No. 10241-04-0

Cobalt chloride (CoCl3)

Catalog No.:AG0007E7 MDL No.:

MF:Cl3Co MW:165.2922

CAS No. 10241-10-8

Benzoic acid, 2-hydroxy-5-[[(2-methyl-1-oxo-2-propen-1-yl)oxy]methyl]-

Catalog No.:AG0007E5 MDL No.:

MF:C12H12O5 MW:236.2207

CAS No. 10241-97-1

1H-Indole-2-carboxylic acid, 5-methyl-

Catalog No.:AG0007E4 MDL No.:MFCD00047166

MF:C10H9NO2 MW:175.1840

CAS No. 10241-98-2

1H-Indole-2-carboxylic acid, 5-chloro-2,3-dihydro-

Catalog No.:AG0007E3 MDL No.:MFCD13031904

MF:C9H8ClNO2 MW:197.6183

© 2019 Angene International Limited. All rights Reserved.